Differentiation inducing factor 3 mediates its anti-leukemic effect through ROS-dependent DRP1-mediated mitochondrial fission and induction of caspase-independent cell death

Oncotarget. 2016 May 3;7(18):26120-36. doi: 10.18632/oncotarget.8319.

Abstract

Differentiation-inducing factor (DIF) defines a group of chlorinated hexaphenones that orchestrate stalk-cell differentiation in the slime mold Dictyostelium discoideum (DD). DIF-1 and 3 have also been reported to have tumor inhibiting properties; however, the mechanisms that underlie the effects of these compounds remain poorly defined. Herein, we show that DIF-3 rapidly triggers Ca2+ release and a loss of mitochondrial membrane potential (MMP) in the absence of cytochrome c and Smac release and without caspase activation. Consistently with these findings, we also detected no evidence of apoptosis in cells treated with DIF-3 but instead found that this compound induced autophagy. In addition, DIF-3 promoted mitochondrial fission in K562 and HeLa cells, as assessed by electron and confocal microscopy analysis. Importantly, DIF-3 mediated the phosphorylation and redistribution of dynamin-related protein 1 (DRP1) from the cytoplasmic to the microsomal fraction of K562 cells. Pharmacological inhibition or siRNA silencing of DRP1 not only inhibited mitochondrial fission but also protected K562 cells from DIF-3-mediated cell death. Furthermore, DIF-3 potently inhibited the growth of imatinib-sensitive and imatinib-resistant K562 cells. It also inhibited tumor formation in athymic mice engrafted with an imatinib-resistant CML cell line. Finally, DIF-3 exhibited a clear selectivity toward CD34+ leukemic cells from CML patients, compared with CD34- cells. In conclusion, we show that the potent anti-leukemic effect of DIF-3 is mediated through the induction of mitochondrial fission and caspase-independent cell death. Our findings may have important therapeutic implications, especially in the treatment of tumors that exhibit defects in apoptosis regulation.

Keywords: DIF-3; autophagy; cell death; leukemia; mitochondria fission.

MeSH terms

  • Animals
  • Apoptosis / drug effects*
  • Biomarkers, Tumor / metabolism
  • Caspases / metabolism
  • Cell Differentiation / drug effects
  • Cell Proliferation / drug effects
  • Dynamins
  • Female
  • GTP Phosphohydrolases / metabolism*
  • Gene Expression Regulation, Leukemic / drug effects*
  • Hexanones / pharmacology*
  • Humans
  • K562 Cells
  • Leukemia / drug therapy
  • Leukemia / metabolism
  • Leukemia / pathology*
  • Mice
  • Mice, Nude
  • Microtubule-Associated Proteins / metabolism*
  • Mitochondria / drug effects
  • Mitochondria / metabolism
  • Mitochondria / pathology
  • Mitochondrial Dynamics / drug effects*
  • Mitochondrial Proteins / metabolism*
  • Phosphorylation / drug effects
  • Reactive Oxygen Species / metabolism*
  • Xenograft Model Antitumor Assays

Substances

  • Biomarkers, Tumor
  • Hexanones
  • Microtubule-Associated Proteins
  • Mitochondrial Proteins
  • Reactive Oxygen Species
  • 1-((3,5-dichloro)-2,6-dihydroxy-4-methoxyphenyl)-1-hexanone
  • Caspases
  • GTP Phosphohydrolases
  • DNM1L protein, human
  • Dynamins